JOYCE FREIDLY: Open Payments
NPI 1457421588 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,756 in 60 payments from 23 companies in 2025. Trend: 2023 $2,012 · 2024 $4,793 · 2025 $1,756
Food & beverage: $1,756
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $449 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $139 |
| Novartis Pharmaceuticals Corporation | 5 | $123 |
| Teleflex LLC | 1 | $114 |
| ABBVIE INC. | 4 | $110 |
| Janssen Scientific Affairs, LLC | 2 | $96 |
| Sumitomo Pharma America, Inc. | 4 | $91 |
| Caris MPI, Inc. | 3 | $82 |
| Dendreon Pharmaceuticals LLC | 3 | $77 |
| Tempus AI, Inc | 3 | $76 |
Products named: ERLEADA, Nubeqa, PLUVICTO, BARRIGEL, Xtandi, BOTOX, MI CANCER SEEK, RYBREVANT.
Industry payments across MD — which companies pay providers there.
